Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Paroxysmal Atrial Fibrillation”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT03539302
What this trial is testing

INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Who this might be right for
Paroxysmal Atrial Fibrillation (PAF)
InCarda Therapeutics, Inc. 176
Not applicableStudy completedNCT00367757
What this trial is testing

STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial

Who this might be right for
Atrial Fibrillation
Abbott Medical Devices 107
Post-approval studies (Phase 4)Study completedNCT00964392
What this trial is testing

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry

Who this might be right for
Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. 437
Large-scale testing (Phase 3)Study completedNCT01639495
What this trial is testing

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Who this might be right for
Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. 148
Not applicableActive Not RecruitingNCT05905835
What this trial is testing

Treatment of PAF With the Synaptic System

Who this might be right for
Paroxysmal Atrial Fibrillation
Synaptic Medical Corporation 128
Not applicableLooking for participantsNCT06324201
What this trial is testing

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Who this might be right for
Paroxysmal Atrial Fibrillation
Heart Rhythm Clinical and Research Solutions, LLC 250
Not applicableStudy completedNCT04356040
What this trial is testing

TactiFlex Paroxysmal Atrial Fibrillation IDE Trial

Who this might be right for
Paroxysmal Atrial Fibrillation
Abbott Medical Devices 355
Not applicableLooking for participantsNCT03355456
What this trial is testing

Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

Who this might be right for
Atrial Fibrillation - Symptomatic
Ohad Ziv 250
Not applicableNot Yet RecruitingNCT06377046
What this trial is testing

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial

Who this might be right for
Atrial FibrillationPermanent Atrial FibrillationPersistent Atrial Fibrillation+2 more
Maastricht University Medical Center 50
Large-scale testing (Phase 3)Study completedNCT00116428
What this trial is testing

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Who this might be right for
Heart DiseasesArrhythmiaAtrial Fibrillation
Biosense Webster, Inc. 167
Post-approval studies (Phase 4)Ended earlyNCT01061931
What this trial is testing

Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Who this might be right for
Symptomatic Paroxysmal Atrial Fibrillation
Charite University, Berlin, Germany 108
Not applicableEnded earlyNCT01103674
What this trial is testing

Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
nContact Surgical Inc. 1
Not applicableStudy completedNCT02463851
What this trial is testing

PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
L.V.A. Boersma 212
Large-scale testing (Phase 3)Study completedNCT00958165
What this trial is testing

Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF

Who this might be right for
Paroxysmal Atrial Fibrillation
CardioFocus 81
Not applicableUnknownNCT03513029
What this trial is testing

Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
VytronUS, Inc. 100
Large-scale testing (Phase 3)Study completedNCT01385202
What this trial is testing

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Who this might be right for
Heart DiseasesArrhythmiaAtrial Fibrillation
Biosense Webster, Inc. 172
Testing effectiveness (Phase 2)Study completedNCT00971204
What this trial is testing

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
CardioFocus 100
Post-approval studies (Phase 4)Study completedNCT00340314
What this trial is testing

A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)

Who this might be right for
Atrial Fibrillation
IRCCS San Raffaele 198
Not applicableUnknownNCT05179902
What this trial is testing

Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation

Who this might be right for
Women and Men Over 18 Years OldAF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AFAble to Give His Non Opposition to Participate to the Study
University Hospital, Clermont-Ferrand 190
Testing effectiveness (Phase 2)Ended earlyNCT01887353
What this trial is testing

The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure

Who this might be right for
Atrial FibrillationHeart Failure
Intermountain Health Care, Inc. 8
Load More Results